Facebook
Twitter
LinkedIn
Forward
Gamechangers in Medicine: Spring 2024
Overview
Purpose
Mary Greeley Medical Center Grand Rounds is a multi-disciplinary clinical activity that maintains, develops, or increases the knowledge, skills, professional performance, and relationships a physician uses to provide services for patients, the public, or the profession.
Target Audience
Physicians, advanced practice providers, nurses, medical students (rotating), non-medical students (rotating), and healthcare administrators.
Learning Objectives
- Classify "Gamechanger" topics by how they affect practice settings.
- Discuss how each "Gamechanger" topic will impact the provision of patient care.
- List possible solutions to clinical problems listed throughout the presentation.
- Assess the clinical trials used to support the content for this presentation.
- Apply the information presented to influence patient care and outcomes at practice sites.
Speaker
Geoffrey C. Wall, PharmD, BCPS, FCCP
Internal Medicine Clinical Pharmacist, Iowa Methodist Medical Center
Ellis Professor of Pharmacy Practice, Drake University College of Pharmacy and Health Sciences
Dr. Wall received his Bachelor's in Pharmacy from the University of Utah in 1992 and his Doctor of Pharmacy from Idaho State University in 1998. He completed a PGY2 in Internal Medicine at Scott and White Hospitals and Clinics and is board-certified in Pharmacotherapy and Geriatrics. Dr. Wall joined UnityPoint Health - Des Moines in 1999. He precepts the Internal Medicine, Critical Care, and Drug Information Elective rotations and is a Professor at Drake University. He is an active member of IPA and ACCP. Dr. Wall's areas of interest include drug allergy/immunology, gastroenterology, rheumatology, and critical care pharmacotherapy.
Location
CE Credits
Accreditation Statements
- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
EDUCATIONAL GRANTS
No ineligible company provided financial support for this continuing education activity.
DISCLOSURES
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.
- Geoffrey C Wall, PharmD, BCPS, FCCP
o Speaker bureau member: Janssen Pharmaceuticals and La Jolla Pharmaceuticals
CME Committee
- No Mary Greeley Medical Center CME Committee member who planned this activity has any financial relationship to disclose relating to the content.
Gifts to the Mary Greeley Medical Center Foundation from Mary Greeley Medical Center, McFarland Clinic, and Availa Bank support this program. The content and selection of speaker(s) are the responsibility of the Mary Greeley Medical Center for Continuing Medical Education Committee, not the sponsors of this program.
DISCLAIMER
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.00 AOA Category 2A